{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:59:52Z","timestamp":1790269192905,"version":"4.1.0"},"reference-count":10,"publisher":"American Society of Hematology","issue":"4","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,2,24]]},"DOI":"10.1182\/bloodadvances.2025017939","type":"journal-article","created":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T17:14:00Z","timestamp":1765559640000},"page":"1395-1399","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":1,"title":["Outcomes of radiation integrated with T-cell\u2013engaging bispecific antibodies in relapsed\/refractory multiple myeloma"],"prefix":"10.1182","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-2256-9586","authenticated-orcid":false,"given":"Heta","family":"Patel","sequence":"first","affiliation":[{"name":"1Department of Medicine, University of Pennsylvania, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harper","family":"Hubbeling","sequence":"additional","affiliation":[{"name":"2Department of Radiation Oncology, University of Pennsylvania, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle","family":"Yu","sequence":"additional","affiliation":[{"name":"3Department of Medicine, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-4344-8490","authenticated-orcid":false,"given":"Maribel","family":"Carpenter","sequence":"additional","affiliation":[{"name":"2Department of Radiation Oncology, University of Pennsylvania, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1662-5086","authenticated-orcid":false,"given":"Michael J.","family":"LaRiviere","sequence":"additional","affiliation":[{"name":"2Department of Radiation Oncology, University of Pennsylvania, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P.","family":"Plastaras","sequence":"additional","affiliation":[{"name":"2Department of Radiation Oncology, University of Pennsylvania, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0939-3843","authenticated-orcid":false,"given":"Adam D.","family":"Cohen","sequence":"additional","affiliation":[{"name":"4Division of Hematology Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivani","family":"Kapur","sequence":"additional","affiliation":[{"name":"4Division of Hematology Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2935-2566","authenticated-orcid":false,"given":"Dan T.","family":"Vogl","sequence":"additional","affiliation":[{"name":"4Division of Hematology Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam J.","family":"Waxman","sequence":"additional","affiliation":[{"name":"4Division of Hematology Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward A.","family":"Stadtmauer","sequence":"additional","affiliation":[{"name":"4Division of Hematology Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2791-5748","authenticated-orcid":false,"given":"Alfred L.","family":"Garfall","sequence":"additional","affiliation":[{"name":"4Division of Hematology Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0703-2518","authenticated-orcid":false,"given":"Sandra","family":"Susanibar-Adaniya","sequence":"additional","affiliation":[{"name":"4Division of Hematology Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2026,2,17]]},"reference":[{"issue":"suppl 2","key":"2026022411383537600_bib1","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1016\/S2152-2650(25)03502-5","article-title":"Clinical outcomes after teclistamb failure in relapsed\/refractory multiple myeloma","volume":"25","author":"Yu","year":"2025","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"1","key":"2026022411383537600_bib2","first-page":"40","article-title":"Management of oligoprogressive and oligopersistent disease in advanced NSCLC","volume":"23","author":"Ravella","year":"2025","journal-title":"Clin Adv Hematol Oncol"},{"issue":"1","key":"2026022411383537600_bib3","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/ajh.27155","article-title":"Incorporating radiation with anti-CD19 chimeric antigen receptor T-cell therapy for relapsed\/refractory non-Hodgkin lymphoma: a multicenter consensus approach","volume":"99","author":"Saifi","year":"2024","journal-title":"Am J Hematol"},{"issue":"10","key":"2026022411383537600_bib4","first-page":"2543","article-title":"Radiation therapy to manage isolated relapse after Chimeric antigen receptor T-cell therapy in multiple myeloma","volume":"110","author":"Srinivas","year":"2025","journal-title":"Haematologica"},{"issue":"suppl 1","key":"2026022411383537600_bib5","doi-asserted-by":"crossref","first-page":"4719","DOI":"10.1182\/blood-2023-190770","article-title":"Upfront radiation therapy (RT) for post-stem cell transplant multiple myeloma (MM) patients with oligo-relapse\/progressive disease: factors associated with favorable outcomes","volume":"142","author":"Fregonese","year":"2023","journal-title":"Blood"},{"issue":"9","key":"2026022411383537600_bib6","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1038\/sj.leu.2404284","article-title":"International uniform response criteria for multiple myeloma","volume":"20","author":"Durie","year":"2006","journal-title":"Leukemia"},{"issue":"24","key":"2026022411383537600_bib7","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1200\/JCO-24-01893","article-title":"International Myeloma Society\/International Myeloma Working Group consensus recommendations on the definition of high-risk multiple myeloma","volume":"43","author":"Avet-Loiseau","year":"2025","journal-title":"J Clin Oncol"},{"issue":"6","key":"2026022411383537600_bib8","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1158\/2643-3230.BCD-24-0354","article-title":"Real-world experience with teclistamab for relapsed\/refractory multiple myeloma from the U.S. Myeloma Immunotherapy Consortium","volume":"6","author":"Razzo","year":"2025","journal-title":"Blood Cancer Discov"},{"issue":"4","key":"2026022411383537600_bib9","first-page":"702","article-title":"Impact of extramedullary disease on outcomes after BCMA-directed CAR T-cell therapy in multiple myeloma: a European retrospective analysis","volume":"7","author":"Gagelmann","year":"2023","journal-title":"Blood Adv"},{"issue":"9","key":"2026022411383537600_bib10","first-page":"516","article-title":"The intersection of radiotherapy and immunotherapy: mechanisms and clinical implications","volume":"20","author":"Demaria","year":"2020","journal-title":"Nat Rev Cancer"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/4\/1395\/2504273\/blooda_adv-2025-017939-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/4\/1395\/2504273\/blooda_adv-2025-017939-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T16:38:42Z","timestamp":1771951122000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/10\/4\/1395\/557303\/Outcomes-of-radiation-integrated-with-T-cell"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,17]]},"references-count":10,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,2,24]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2025017939","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,2,24]]},"published":{"date-parts":[[2026,2,17]]}}}